SIMONE, Isabella Laura
 Distribuzione geografica
Continente #
NA - Nord America 14.082
AS - Asia 5.419
EU - Europa 4.232
SA - Sud America 1.386
AF - Africa 246
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 9
Totale 25.387
Nazione #
US - Stati Uniti d'America 13.889
SG - Singapore 2.061
IT - Italia 1.386
CN - Cina 1.150
BR - Brasile 1.100
HK - Hong Kong 1.082
SE - Svezia 534
DE - Germania 428
RU - Federazione Russa 400
UA - Ucraina 345
FI - Finlandia 329
FR - Francia 321
VN - Vietnam 306
GB - Regno Unito 214
IN - India 165
BD - Bangladesh 145
CA - Canada 101
AR - Argentina 90
IQ - Iraq 83
CI - Costa d'Avorio 69
ID - Indonesia 65
ZA - Sudafrica 53
TR - Turchia 50
EC - Ecuador 42
BE - Belgio 39
PK - Pakistan 39
CO - Colombia 37
MX - Messico 37
PL - Polonia 34
IE - Irlanda 32
JP - Giappone 32
MA - Marocco 31
UZ - Uzbekistan 31
VE - Venezuela 31
ES - Italia 29
PH - Filippine 27
NL - Olanda 26
SA - Arabia Saudita 25
AT - Austria 24
AE - Emirati Arabi Uniti 22
CL - Cile 22
UY - Uruguay 21
JO - Giordania 19
LT - Lituania 17
MY - Malesia 17
PY - Paraguay 15
TN - Tunisia 15
BO - Bolivia 14
KE - Kenya 14
JM - Giamaica 13
OM - Oman 13
ET - Etiopia 12
PE - Perù 12
CR - Costa Rica 11
AZ - Azerbaigian 10
BG - Bulgaria 8
EG - Egitto 8
NG - Nigeria 8
RO - Romania 8
AU - Australia 7
EU - Europa 7
KZ - Kazakistan 7
NI - Nicaragua 7
NP - Nepal 7
PT - Portogallo 7
RS - Serbia 7
AO - Angola 6
BY - Bielorussia 6
DZ - Algeria 6
GE - Georgia 6
IL - Israele 6
IR - Iran 6
KW - Kuwait 6
TW - Taiwan 6
CW - ???statistics.table.value.countryCode.CW??? 5
LB - Libano 5
SN - Senegal 5
AL - Albania 4
BH - Bahrain 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
EE - Estonia 4
GA - Gabon 4
GR - Grecia 4
KG - Kirghizistan 4
KR - Corea 4
LV - Lettonia 4
TH - Thailandia 4
CH - Svizzera 3
MD - Moldavia 3
PA - Panama 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BF - Burkina Faso 2
BW - Botswana 2
CY - Cipro 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
Totale 25.346
Città #
Fairfield 1.523
Ashburn 1.349
Woodbridge 1.170
Singapore 1.090
Chandler 901
Houston 812
Jacksonville 786
Seattle 641
San Jose 633
Hong Kong 609
Wilmington 558
Cambridge 529
Milan 521
Ann Arbor 487
Nyköping 369
Beijing 280
New York 261
Lawrence 224
Roxbury 224
Lauterbourg 207
Los Angeles 187
Dallas 184
Nanjing 180
Boardman 158
Des Moines 150
Rome 143
Helsinki 124
Ho Chi Minh City 103
Bari 101
Princeton 94
Santa Clara 93
San Diego 75
Council Bluffs 74
São Paulo 73
Brooklyn 72
Abidjan 69
Nanchang 63
Munich 61
Inglewood 60
Turin 59
Columbus 58
Hanoi 56
Hebei 55
London 52
Dearborn 51
Orem 51
Jiaxing 50
Buffalo 49
Shenyang 48
Figino 47
Rio de Janeiro 44
Denver 43
San Francisco 42
Frankfurt am Main 41
Tianjin 39
Falls Church 38
Brussels 37
Atlanta 36
Dong Ket 36
Belo Horizonte 35
Paris 35
Chicago 33
Dublin 32
Marseille 31
Tokyo 30
Baghdad 29
Jakarta 29
Norwalk 29
Changsha 28
Moscow 26
Tashkent 26
Montreal 25
Warsaw 25
North Bergen 24
Phoenix 24
Redwood City 24
Guangzhou 23
Nuremberg 23
Pune 23
Boston 21
Johannesburg 21
The Dalles 21
Shanghai 20
Brasília 19
Clifton 19
Curitiba 19
Falkenstein 18
Toronto 18
Quito 17
Secaucus 17
Washington 17
Chennai 16
Stockholm 16
Taranto 16
Amman 15
Guayaquil 15
Istanbul 15
Lahore 15
Naples 15
Campinas 14
Totale 17.088
Nome #
Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.J Neurol Sci. 2001 Jan 1;182(2):143-50 676
Adherence to riluzole in patients with amyotrophic lateral sclerosis: An observational study 673
Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis 359
Corrigendum: Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis 242
Dysregulation of MicroRNAs and Target Genes Networks in Peripheral Blood of Patients With Sporadic Amyotrophic Lateral Sclerosis 199
Episodic memory and learning rates in amyotrophic lateral sclerosis without dementia 190
Convexal subarachnoid hemorrhage and acute ischemic stroke: a border zone matter? 187
A rare association between multiple sclerosis and Charcot-Marie-Tooth type 1B 187
Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: A retrospective observational study 183
Frontal assessment battery for detecting executive dysfunction in amyotrophic lateral sclerosis without dementia: a retrospective observational study 182
Assisting persons with advanced amyotrophic lateral sclerosis in their leisure engagement and communication needs with a basic technology-aided program 182
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis 179
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis 177
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis 172
Nutritional prognostic factors for survival in amyotrophic lateral sclerosis patients undergone percutaneous endoscopic gastrostomy placement 166
Pseudobulbar affect as a negative prognostic indicator in amyotrophic lateral sclerosis 161
Multiparametric unconventional MRI study in early stage of ALS disease 158
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 154
Cerebrospinal Fluid and Clinical Profiles in Adult Type 2–3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience 152
IMMUNOPATOLOGIA DELLA SCLEROSI MULTIPLA 150
Double-Blind Placebo-Controlled Trial on the Use of Acetyl-L-Carnitine for the Treatment of Amyotrophic Lateral Sclerosis (P04.151) 148
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. 148
Analisi longitudinale dei livelli sierici di ICAM-1 solubile e dei subsets di linfociti T in pazienti con Sclerosi Multipla a decorso remittente in trattamento con IFNb-1b 147
A Novel CSF1R Mutation in a Patient with Clinical and Neuroradiological Features of Hereditary Diffuse Leukoencephalopathy with Axonal Spheroids 145
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 144
Hirayama disease: the importance of an early diagnosis 143
MR evaluation of encephalic leukoaraiosis in sudden sensorineural hearing loss (SSNHL) patients 140
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 139
Motor-evoked potentials in amyotrophic lateral sclerosis: potential implications in detecting subclinical UMN involvement in lower motor neuron phenotype 139
The importance of maintaining the same order of performance of lung function and SNIP tests in patients with amyotrophic lateral sclerosis 138
ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy 137
The role of imaging in Hirayama disease 136
Intrathecal immune response in human immunodeficiency virus infection 135
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial) 135
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 133
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study 132
Verbal Learning Abilities in ALS Patients (P01.109) 132
1H-MR Spectroscopy profiles in normal appearing white matter(NAWM) of clinically isolated sindromes suggestive of multiple sclerosis(CIS) 131
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study. 131
Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study 129
HFE p.H63D polymorphism does not influence ALS phenotype and survival 127
Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG. 125
Brain Cortex Thinning in Motor And Extra-motor Areas in Amyotrophyc Lateral Sclerosis 124
Long term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience 124
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS 123
Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy 123
Elevated plasma homocystein levels in patients with Amyotrophic lteral sclerosis 121
1H-MRSA comparison of normal appearing white matter in different clinical MS subgroups 121
Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled,multicentre clinical trial for colchicine in ALS (Co-ALS) 119
Brain cortex thinning in motor and extra-motor areas in amyotrophic lateral sclerosis 118
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD 118
High resolution proton MR-spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques 114
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 114
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients 114
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues 113
Trauma and amyotrophic lateral sclerosis: a case-control study from a population-based registry. 112
G-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial) 112
99mTc-HM-PAO SPET and proton magnetic resonance spectroscopy in patients with ischaemic cerebral infarction 111
N-Acetyl-Aspartate (NAA) and Neurofilament-Light Chain (NF-L) in biological fluids as markers of neurodegeneration in ALS 110
Alzheimer disease: comparison of 99mTc-HMPAO SPET and 1H-MRS data 110
Is cerebrospinal fluid amyloid-β42 a promising biomarker of response to nusinersen in adult spinal muscular atrophy patients? 110
Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis. 109
Prognostic factors in ALS: A critical review 108
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. 108
BRAIN CORTEX THINNING IN MOTOR AND EXTRA-MOTOR AREAS IN AMYOTROPHIC LATERAL SCLEROSIS 107
Relationships between regional cortical atrophy and cognitive dysfunction in non-demented ALS patients 105
99Tcm-HMPAO SPET and 1H-MRS (Proton Magnetic Resonance Spectroscopy) in patients with ischaemic cerebral infarction 105
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances 104
Incidence of amyotrophic lateral sclerosis in Europe 103
Life-threatening ADEM in an immunocompetent pregnant woman with concomitant asymptomatic Cytomegalovirus infection 103
Cerebrospinal Fluid and Serum Neurofilament Light Chain Levels in ALS Patients 102
Intra blood-barrier (BBB) immune rersponse in HIV-infected patients 101
null 101
A novel KIF5A mutation in an Italian family marked by spastic paraparesis and congenital deafness 101
A 71-nucleotide deletion in the periaxin gene in an Italian patient with late-onset slowly progressive demyelinating CMT 101
null 100
Adult-onset Rasmussen's encephalitis: anatomical-electrographic-clinical features of 7 Italian cases 100
dentification of a point mutation impairing the binding between Aquaporin-4 and the Neuromyelitis Optica autoantibodies 98
. Amyotrophic lateral sclerosis: a new missense mutation in the SOD1 gene 98
A case of Landau-Kleffner syndrome secondary to inflammatory demyelinating disease 96
null 95
Is Frontal Assessment Battery a useful instrument to detect cognitive impairment in ALS?. 95
Inclusion of motor evoked abnormalities in amyotrophic lateral sclerosis: a diagnostic algorithm to early classify lower motor neuron phenotypes 95
Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study 94
Pseudobulbar affect (PBA) in an incident ALS cohort: results from the Apulia registry (SLAP). 93
Benign and malignant MS:clinical and 1H-MRS parameters associated with different MS courses 93
Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy 93
Brain cortical thinning in Motor and Extra-motor areas in Amyotrophic Lateral Sclerosis 91
Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol. 2007 Feb;28(2):255-9 90
The contribution of (1)H-magnetic resonance spectroscopy in defining the pathophysiology of multiple sclerosis. 90
Acute changes in blood-CSF barrier permselectivity to serum proteins after intrathecal methotrexate and CNS irradiation 90
N-Acetyl-Aspartate (NAA) and Neurofilament Light-Chain (NF-L) in Biological Fluids as Markers of Neurodegeneration in ALS 89
Isoelectric focusing and crossed immunoelectrofocusing of cerebrospinal fluid proteins in neurological disorders 89
null 88
Disease progression and cortical thinning in amyotrophic lateral sclerosis 87
Acoustic Voice Analysis as a Useful Tool to Discriminate Different ALS Phenotypes 87
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3. 86
The Functional Interaction of KATP and BK Channels with Aquaporin-4 in the U87 Glioblastoma Cell 85
Patterns of multiple sclerosis (MS) plaques by magnetic resonance imaging (MRI) and proton-MR spectroscopy (1H-MRS) evaluation 85
Gender Differences of Cortical Thickness in Amyotrophic Lateral Sclerosis 85
Totale 13.704
Categoria #
all - tutte 101.306
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.306


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.878 55 78 16 37 82 172 46 72 99 110 262 849
2022/20232.261 365 220 157 211 293 255 32 249 393 14 40 32
2023/2024809 57 153 51 39 54 232 21 34 18 21 5 124
2024/20253.356 107 65 322 119 88 285 207 274 173 194 491 1.031
2025/20268.042 1.070 279 410 718 660 431 943 245 660 724 925 977
2026/2027264 264 0 0 0 0 0 0 0 0 0 0 0
Totale 26.189